Price $6.55 |
Market Cap
26.1M
|
Sector Health Care |
Div. Growth
-62.50%
|
|
P/E
17.9
|
P/B
1.67
|
P/S
48.05
|
Dividend %
0.40%
|
|
P/CF
-
|
P/FCF
17.0
|
Op. Cash Flow
1.6K
|
FCF
0.4
|
|
Op. Margin
36.50%
|
Net Margin
272.80%
|
ROE
8.90%
|
ROI
0.60%
|
|
ROA
6.20%
|
EPS Growth
116.60%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.33 | - | - | 89.6M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $2.40 | - | - | 30M | Strong Buy |
| Pen Inc (PENC) | $1.46 | - | - | 5.8M | Strong Buy |
| Acura Pharmaceuticals, Inc. (ACUR) | $0.56 | - | - | 5.9M | Strong Buy |
| Perrigo Company PLC (PRGO) | $74.70 | - | 0.90% | 10.03B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
